Table 2.

Characteristics and outcome of patients with cement pulmonary embolism

Number	Age	Gender	Underlying Etiologyb	Primary Cancer	Location	Type of PE	Symptoms	Anticoagulation	Status	Survival (Months)
1	31	F	Malignant	Breast	T12-L2	Main	Dyspnea, Tachycardia, Hypoxia	No	Dead	8.5
2	41	F	Malignant	Breast	L1-L5	segmental	Dyspnea, Tachycardia, Hypoxia	LMWH	Dead	1.5
3	78	F	Osteoporosis	Lymphoma	L1	segmental	No	No	Alive	53
4	55	M	Osteoporosis	Lung	L2- L5	Lobar	No	No	Dead	12
5	81	F	Osteoporosis	Lymphoma	L5	subsegmental	No	LMWH	Alive	48
6	37	M	Malignant	MM	T9–12,L1	subsegmental	No	No	Dead	NAa
7	50	F	Malignant	MM	T5-T8	subsegmental	No	No	Dead	24
8	63	M	Malignant	MM	L1-L3	Lobar	No	No	Dead	20
9	50	M	Malignant	MM	L2-L4	subsegmental	No	No	Alive	48
10	68	M	Malignant	MM	T12,L1,L2	subsegmental	Dyspnea, Chest pain, Cough, Tachycardia, Hypoxia	No	Dead	4.5
11	60	F	Malignant	Breast	L4	subsegmental	No	Already on LMWH	Dead	11
12	45	F	Malignant	MM	L3-L5	Main	Dyspnea	LMWH	Dead	8
13	45	F	Malignant	MM	T12,L1,L2	Lobar	Dyspnea	LMWH	Dead	8

LMWH Low molecular weight heparin, MM Multiple Myeloma

^aNA: Data not available, ^ball in cancer patients